FBT ETF
First Trust NYSE Arca Biotechnology Index Fund
FBT ETF Overview
FBT ETF (First Trust NYSE Arca Biotechnology Index Fund) is managed by First Trust Portfolios (US) with $2.92B in net assets. FBT expense ratio is 0.55%, holding 62 positions across sectors including Health Care, Information Technology. Inception date: 2006-06-19.
FBT performance shows a YTD return of 19.06%. The 1-year return is 49.49% and the 5-year return is 7.99%.
FBT top holdings include Halozyme Therapeutics Inc (4.3%), Neogenomics Inc (3.9%), Repligen Corp (3.9%), Corcept Therapeutics Incorporated (3.8%), Beigene, Ltd. Adr (3.7%). Go to all FBT holdings, FBT sectors, or FBT dividends.
FBT can be compared against other funds. Use FBT overlap to find shared positions, or FBT vs another fund for a side-by-side view. FBT alternatives are available via the screener, along with tax-loss harvesting opportunities.